Italian study to evaluate the efficacy of retinoic acid and cabergoline therapy in combination in Cushing's disease. Italian study to evaluate the efficacy of retinoic acidand cabergoline therapy in combination in Cus ...
Medical combination therapy with retinoic acid and cabergoline in ACTH-secreting pituitary adenoma: a prospective and randomized study. - CRACCA Medical combination therapy with retinoic acidand cabergoline in ACTH-secreting pituitary adenoma: a ...
Cushing's disease in patients in whom pituitary surgery has not been curative or in situations where it is contraindicated or refused by patient. MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disease;System Organ Class: 100000004860;Therapeutic area: Diseases [C] - Hormonal diseases [C19] Cushing's disease in patients in whom pituitary surgery has not been curative or in situations where ...
Evaluation of the benefit-risk profile of retinoic acid in the treatment of Cushing`s disease - Retinoic acid in Cushing`s disease Evaluation of the benefit-risk profile of retinoic acidin the treatment of Cushing`s disease - Retin ...
Evaluation of the benefit-risk profile of retinoic acid in the treatment of Cushing`s disease - Retinoic acid in Cushing`s disease Evaluation of the benefit-risk profile of retinoic acidin the treatment of Cushing`s disease - Retin ...